Development and Validation of a Nomogram for Predicting the Long-Term Survival in Patients With Chronic Thromboembolic Pulmonary Hypertension

被引:3
|
作者
Hu, Song [1 ]
Tan, Jiang-Shan [1 ]
Liu, Sheng [2 ]
Guo, Ting-Ting [1 ]
Song, Wu [2 ]
Peng, Fu-Hua [1 ]
Wu, Yan [1 ]
Gao, Xin [1 ]
Hua, Lu [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Thrombosis Ctr,Natl Ctr Cardiovasc Dis,State Key, Natl Clin Res Ctr Cardiovasc Dis,Key Lab Pulm Vas, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Adult Cardiac Surg Ctr, Natl Ctr Cardiovasc Dis,Dept Cardiac Surg, Beijing, Peoples R China
关键词
ARTERIAL-HYPERTENSION; RISK STRATIFICATION; MANAGEMENT; HYPOXIA;
D O I
10.1016/j.amjcard.2021.09.045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There remains a lack of prognosis models for patients with chronic thromboembolic pulmonary hypertension (CTEPH). This study aims to develop a nomogram predicting 3-, 5-, and 7-year survival in patients with CTEPH and verify the prognostic model. Patients with CTEPH diagnosed in Fuwai Hospital were enrolled consecutively between May 2013 and May 2019. Among them, 70% were randomly split into a training set and the other 30% as a validation set for external validation. Cox proportional hazards model was used to identify the potential survival-related factors which were candidate variables for the establishment of nomogram and the final model was internally validated by the bootstrap method. A total of 350 patients were included in the final analysis and the median followup period of the whole cohort was 51.2 months. Multivariate analysis of Cox proportional hazards regression showed body mass index, mean right atrial pressure, N-terminal probrain natriuretic peptide (per 500 ng/ml increase in concentration), presence of anemia, and main treatment choice were the independent risk factors of mortality. The nomogram demonstrated good discrimination with the corrected C-index of 0.82 in the training set, and the C-index of 0.80 (95% CI: 0.70 to 0.91) in the external validation set. The calibration plots also showed a good agreement between predicted and actual survival in both training and validation sets. In conclusion, we developed an easy-to-use nomogram with good apparent performance using 5 readily available variables, which may help physicians to identify CTEPH patients at high risk for poor prognosis and implement medical interventions. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:109 / 116
页数:8
相关论文
共 50 条
  • [41] Does Duke Activity Status Index help predicting functional exercise capacity and long-term prognosis in patients with pulmonary hypertension?
    Mustafaoglu, Rustem
    Demir, Rengin
    Aslan, Goksen Kuran
    Sinan, Umit Yasar
    Zeren, Melih
    Kucukoglu, Mehmet Serdar
    RESPIRATORY MEDICINE, 2021, 181
  • [42] Long-term therapy with inhaled iloprost in patients with pulmonary hypertension
    Olschewski, Horst
    Hoeper, Marius M.
    Behr, Juergen
    Ewert, Ralf
    Meyer, Andreas
    Borst, Mathias M.
    Winkler, Joerg
    Pfeifer, Michael
    Wilkens, Heinrike
    Ghofrani, Hossein Ardeschir
    Nikkho, Sylvia
    Seeger, Werner
    RESPIRATORY MEDICINE, 2010, 104 (05) : 731 - 740
  • [43] Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism
    Yang, Suqiao
    Yang, Yuanhua
    Zhai, Zhenguo
    Kuang, Tuguang
    Gong, Juanni
    Zhang, Shuai
    Zhu, Jianguo
    Liang, Lirong
    Shen, Ying H.
    Wang, Chen
    JOURNAL OF THORACIC DISEASE, 2015, 7 (11) : 1927 - 1938
  • [44] Assessment of oxygenation after balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension
    Matsuoka, Yoichiro
    Taniguchi, Yu
    Miwa, Keisuke
    Sumimoto, Keiko
    Tsuboi, Yasunori
    Onishi, Hiroyuki
    Yanaka, Kenichi
    Emoto, Noriaki
    Hirata, Kenichi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 333 : 188 - 194
  • [45] The Role of Strain by Cardiac Magnetic Resonance Imaging in Predicting the Prognosis of Patients with Chronic Thromboembolic Pulmonary Hypertension
    Zhang, Xuefei
    Guo, Xiaojuan
    Zhang, Bowen
    Yang, Qi
    Gong, Juanni
    Yang, Suqiao
    Li, Jifeng
    Kuang, Tuguang
    Miao, Ran
    Yang, Yuanhua
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
  • [46] REVEAL risk score in patients with chronic thromboembolic pulmonary hypertension receiving riociguat
    Benza, Raymond L.
    Farber, Harrison W.
    Frost, Adaani
    Gruenig, Ekkehard
    Hoeper, Marius M.
    Busse, Dennis
    Meier, Christian
    Nikkho, Sylvia
    Ghofrani, Hossein-Ardeschir
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (07) : 836 - 843
  • [47] Long-Term Survival of Adult Patients With Atrial Septal Defect With Regards to Defect Closure and Pulmonary Hypertension
    Popelova, Jana Rubackova
    Tomkova, Marketa
    Tomek, Jakub
    Zivna, Renata
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [48] Treatment of patients with chronic thromboembolic pulmonary hypertension: focus on riociguat
    Smith, Zachary R.
    Makowski, Charles T.
    Awdish, Rana L.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 957 - 964
  • [49] Prevalence and Determinants of Depression and Anxiety in Patients With Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
    Mitsuyama, Yuzuki
    Goda, Ayumi
    Takeuchi, Kaori
    Kikuchi, Hanako
    Inami, Takumi
    Soejima, Kyoko
    Kohno, Takashi
    CIRCULATION REPORTS, 2025, 7 (04) : 285 - 292
  • [50] Efficacy of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension patients with pulmonary comorbidity
    Wang, Yeqing
    Guo, Dichen
    Gong, Juanni
    Wang, Jianfeng
    Yang, Yuanhua
    Zhang, Xinyuan
    Hu, Huimin
    Ma, Yaning
    Lv, Xiuzhang
    Li, Yidan
    IJC HEART & VASCULATURE, 2024, 51